Поиск
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.

Список литературы

  1. Jauniaux E. et al. Placenta Praevia and Placenta Accreta: Diagnosis and Management // BJOG An Int. J. Obstet. Gynaecol. 2019. Vol. 126, № 1. P. e1–e48.
  2. De Mucio B. et al. A systematic review and meta‐analysis of cesarean delivery and other uterine surgery as risk factors for placenta accreta // Int. J. Gynecol. Obstet. 2019. Vol. 147, № 3. P. 281–291.
  3. Chen Y. et al. Persistent hypoxia induced autophagy leading to invasiveness of trophoblasts in placenta accreta. // J. Matern. Fetal. Neonatal Med. 2021. Vol. 34, № 8. P. 1297–1303.
  4. Timor-Tritsch I.E. et al. Cesarean scar pregnancy and early placenta accreta share common histology. // Ultrasound Obstet. Gynecol. 2014. Vol. 43, № 4. P. 383–395.
  5. Society of Gynecologic Oncology et al. Placenta Accreta Spectrum. // Am. J. Obstet. Gynecol. 2018. Vol. 219, № 6. P. B2–B16.
  6. Jauniaux E., Bhide A. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis. // Am. J. Obstet. Gynecol. 2017. Vol. 217, № 1. P. 27–36.
  7. Morlando M. et al. Reproductive outcome after cesarean scar pregnancy: A systematic review and meta-analysis. // Acta Obstet. Gynecol. Scand. 2020. Vol. 99, № 10. P. 1278–1289.
  8. Jauniaux E. et al. Epidemiology of placenta previa accreta: a systematic review and metaanalysis. // BMJ Open. 2019. Vol. 9, № 11. P. e031193.
  9. Martimucci K. et al. Interpregnancy interval and abnormally invasive placentation. // Acta Obstet. Gynecol. Scand. 2019. Vol. 98, № 2. P. 183–187.
  10. Castaneda S., Karrison T., Cibils L.A. Peripartum hysterectomy. // J. Perinat. Med. 2000. Vol. 28, № 6. P. 472–481.
  11. Iacovelli A. et al. Risk factors for abnormally invasive placenta: a systematic review and metaanalysis. // J. Matern. Fetal. Neonatal Med. 2020. Vol. 33, № 3. P. 471–481.
  12. Fitzpatrick K.E. et al. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. // PLoS One. 2012. Vol. 7, № 12. P. e52893.
  13. Calì G. et al. Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta‐analysis // Ultrasound Obstet. Gynecol. 2018. Vol. 51, № 2. P. 169–175.
  14. Kohn J.R. et al. Pregnancy after endometrial ablation: a systematic review. // BJOG. 2018. Vol. 125, № 1. P. 43–53.
  15. Read J.A., Cotton D.B., Miller F.C. Placenta accreta: changing clinical aspects and outcome. // Obstet. Gynecol. 1980. Vol. 56, № 1. P. 31–34.
  16. Wu S., Kocherginsky M., Hibbard J.U. Abnormal placentation: twenty-year analysis. // Am. J. Obstet. Gynecol. 2005. Vol. 192, № 5. P. 1458–1461.
  17. Amin M.B. et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. // CA. Cancer J. Clin. 2017. Vol. 67, № 2. P. 93–99.
  18. Federal State Statistics Service (Rosstat). Russian Statistical Yearbook. 2019. 694 p.
  19. Neilson J.P. Interventions for suspected placenta praevia. // Cochrane database Syst. Rev. 2003. № 2. P. CD001998.
  20. Erm Jauniaux,Z Alfirevic,A G Bhide,M A Belfort,G J Burton,S L Collins,S Dornan,D Jurkovic,G Kayem,J Kingdom,R Silver L.S. Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green-top Guideline No. 27a // BJOG An Int. J. Obstet. Gynaecol. 2018.
  21. Jauniaux E. et al. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. // Int. J. Gynaecol. Obstet. 2019. Vol. 146, № 1. P. 20–24.
  22. Palacios-Jaraquemada J.M. et al. Systematic review on near miss cases of placenta accreta spectrum disorders: correlation with invasion topography, prenatal imaging, and surgical outcome. // J. Matern. Fetal. Neonatal Med. 2020. Vol. 33, № 19. P. 3377–3384.
  23. Expert Panel on Women’s Imaging et al. ACR Appropriateness Criteria® Placenta Accreta Spectrum Disorder. // J. Am. Coll. Radiol. 2020. Vol. 17, № 5S. P. S207–S214.
  24. Savelieva G.M. et al. [Development and practical implementation of organ preservation surgery in case of placenta accreta in patients with a scar on the uterus]. // Probl. sotsial’noi Gig. Zdr. i Istor. meditsiny. 2019. Vol. 27, № Special Issue. P. 693–698.
  25. D’Antonio F. et al. First-trimester detection of abnormally invasive placenta in high-risk women: systematic review and meta-analysis. // Ultrasound Obstet. Gynecol. 2018. Vol. 51, № 2. P. 176– 183.
  26. Panaiotova J. et al. Screening for morbidly adherent placenta in early pregnancy. // Ultrasound Obstet. Gynecol. 2019. Vol. 53, № 1. P. 101–106.
  27. Hobson S.R. et al. No. 383-Screening, Diagnosis, and Management of Placenta Accreta Spectrum Disorders. // J. Obstet. Gynaecol. Can. 2019. Vol. 41, № 7. P. 1035–1049.
  28. Melcer Y. et al. Impact of targeted scanning protocols on perinatal outcomes in pregnancies at risk of placenta accreta spectrum or vasa previa. // Am. J. Obstet. Gynecol. 2018. Vol. 218, № 4. P. 443.e1-443.e8.
  29. D’Antonio F., Iacovella C., Bhide A. Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. // Ultrasound Obstet. Gynecol. 2013. Vol. 42, № 5. P. 509–517.
  30. Buca D. et al. Influence of prenatal diagnosis of abnormally invasive placenta on maternal outcome: systematic review and meta-analysis. // Ultrasound Obstet. Gynecol. 2018. Vol. 52, № 3. P. 304–309.
  31. Collins S.L. et al. Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP). // Ultrasound Obstet. Gynecol. 2016. Vol. 47, № 3. P. 271–275.
  32. Jauniaux E. et al. FIGO consensus guidelines on placenta accreta spectrum disorders: Prenatal diagnosis and screening. // Int. J. Gynaecol. Obstet. 2018. Vol. 140, № 3. P. 274–280.
  33. Alfirevic Z. et al. Pro forma for ultrasound reporting in suspected abnormally invasive placenta (AIP): an international consensus. // Ultrasound Obstet. Gynecol. 2016. Vol. 47, № 3. P. 276– 278.
  34. D’Antonio F. et al. Prenatal identification of invasive placentation using magnetic resonance imaging: systematic review and meta-analysis. // Ultrasound Obstet. Gynecol. 2014. Vol. 44, № 1. P. 8–16.
  35. Familiari A. et al. Diagnostic accuracy of magnetic resonance imaging in detecting the severity of abnormal invasive placenta: a systematic review and meta-analysis. // Acta Obstet. Gynecol. Scand. 2018. Vol. 97, № 5. P. 507–520.
  36. Poder L. et al. ACR Appropriateness Criteria® Placenta Accreta Spectrum Disorder // J. Am. Coll. Radiol. 2020. Vol. 17, № 5. P. S207–S214.
  37. Jha P. et al. Society of Abdominal Radiology (SAR) and European Society of Urogenital Radiology (ESUR) joint consensus statement for MR imaging of placenta accreta spectrum disorders. // Eur. Radiol. 2020. Vol. 30, № 5. P. 2604–2615.
  38. Hecht J.L. et al. Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel. // Mod. Pathol. 2020. Vol. 33, № 12. P. 2382–2396.
  39. Wing D.A., Paul R.H., Millar L.K. Management of the symptomatic placenta previa: a randomized, controlled trial of inpatient versus outpatient expectant management. // Am. J. Obstet. Gynecol. 1996. Vol. 175, № 4 Pt 1. P. 806–811.
  40. Publications Committee S. for M.-F.M., Belfort M.A. Placenta accreta. // Am. J. Obstet. Gynecol. 2010. Vol. 203, № 5. P. 430–439.
  41. Rac M.W.F. et al. Placenta accreta and vaginal bleeding according to gestational age at delivery. // Obstet. Gynecol. 2015. Vol. 125, № 4. P. 808–813.
  42. Bowman Z.S. et al. Risk factors for unscheduled delivery in patients with placenta accreta. // Am. J. Obstet. Gynecol. 2014. Vol. 210, № 3. P. 241.e1-6.
  43. Fishman S.G., Chasen S.T. Risk factors for emergent preterm delivery in women with placenta previa and ultrasound findings suspicious for placenta accreta. // J. Perinat. Med. 2011. Vol. 39, № 6. P. 693–696.
  44. Pri-Paz S. et al. Comparison between emergent and elective delivery in women with placenta accreta. // J. Matern. Fetal. Neonatal Med. 2013. Vol. 26, № 10. P. 1007–1011.
  45. Warshak C.R. et al. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. // Obstet. Gynecol. 2010. Vol. 115, № 1. P. 65–69.
  46. Robinson B.K., Grobman W.A. Effectiveness of timing strategies for delivery of individuals with placenta previa and accreta. // Obstet. Gynecol. 2010. Vol. 116, № 4. P. 835–842.
  47. Seoud M.A. et al. Placenta accreta: Elective versus emergent delivery as a major predictor of blood loss. // J. Neonatal. Perinatal. Med. 2017. Vol. 10, № 1. P. 9–15.
  48. Angstmann T. et al. Surgical management of placenta accreta: a cohort series and suggested approach. // Am. J. Obstet. Gynecol. 2010. Vol. 202, № 1. P. 38.e1-9.
  49. Collins S.L. et al. Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta. // Am. J. Obstet. Gynecol. 2019. Vol. 220, № 6. P. 511–526.
  50. Eller A.G. et al. Optimal management strategies for placenta accreta. // BJOG. 2009. Vol. 116, № 5. P. 648–654.
  51. Jauniaux E. et al. Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green-top Guideline No. 27a. // BJOG. 2019. Vol. 126, № 1. P. e1–e48.
  52. Taylor N.J., Russell R. Anaesthesia for abnormally invasive placenta: a single-institution case series. // Int. J. Obstet. Anesth. 2017. Vol. 30. P. 10–15.
  53. Курцер М.А. et al. Placenta accreta // Obstet. Gynecol. 2002. Vol. 99, № 1. P. 169–170.
  54. Nguyen-Lu N. et al. Mode of anesthesia and clinical outcomes of patients undergoing Cesarean delivery for invasive placentation: a retrospective cohort study of 50 consecutive cases. // Can. J. Anaesth. 2016. Vol. 63, № 11. P. 1233–1244.
  55. Khokhar R. et al. Placenta accreta and anesthesia: A multidisciplinary approach // Saudi J. Anaesth. 2016. Vol. 10, № 3. P. 332.
  56. Kocaoglu N. et al. Management of anesthesia for cesarean section in parturients with placenta previa with/without placenta accreta: a retrospective study. // Ginekol. Pol. 2012. Vol. 83, № 2. P. 99–103.
  57. Nguyen-Lu N. et al. Mode of anesthesia and clinical outcomes of patients undergoing Cesarean delivery for invasive placentation: a retrospective cohort study of 50 consecutive cases // Can. J. Anesth. Can. d’anesthésie. 2016. Vol. 63, № 11. P. 1233–1244.
  58. Markley J.C. et al. Neuraxial Anesthesia During Cesarean Delivery for Placenta Previa With Suspected Morbidly Adherent Placenta: A Retrospective Analysis. // Anesth. Analg. 2018. Vol. 127, № 4. P. 930–938.
  59. Schmidt G.A. et al. Liberation From Mechanical Ventilation in Critically Ill Adults: Executive Summary of an Official American College of Chest Physicians/American Thoracic Society Clinical Practice Guideline // Chest. 2017. Vol. 151, № 1. P. 160–165.
  60. Muñoz M. et al. Patient blood management in obstetrics: prevention and treatment of postpartum haemorrhage. A NATA consensus statement. // Blood Transfus. 2019. Vol. 17, № 2. P. 112–136.
  61. Spruit M.A. et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. // Am. J. Respir. Crit. Care Med. 2013. Vol. 188, № 8. P. e13-64.
  62. Smulian J.C. et al. Invasive placental disease: the impact of a multi-disciplinary team approach to management. // J. Matern. Fetal. Neonatal Med. 2017. Vol. 30, № 12. P. 1423–1427.
  63. Al-Khan A. et al. Maternal and Fetal Outcomes in Placenta Accreta After Institution of TeamManaged Care // Reprod. Sci. 2014. Vol. 21, № 6. P. 761–771.
  64. Eller A.G. et al. Maternal Morbidity in Cases of Placenta Accreta Managed by a Multidisciplinary Care Team Compared With Standard Obstetric Care // Obstet. Gynecol. 2011. Vol. 117, № 2. P. 331–337.
  65. Shamshirsaz A.A. et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. // Am. J. Obstet. Gynecol. 2015. Vol. 212, № 2. P. 218.e1-9.
  66. Silver R.M. et al. Center of excellence for placenta accreta. // Am. J. Obstet. Gynecol. 2015. Vol. 212, № 5. P. 561–568.
  67. Shamshirsaz A.A. et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach // Am. J. Obstet. Gynecol. 2015. Vol. 212, № 2. P. 218.e1-218.e9.
  68. Singh S.S. et al. Surgical safety checklist in obstetrics and gynaecology. // J. Obstet. Gynaecol. Can. 2013. Vol. 35, № 1. P. 82–85.
  69. Palacios-Jaraquemada J.M. et al. Placenta accreta spectrum: a hysterectomy can be prevented in almost 80% of cases using a resective-reconstructive technique. // J. Matern. Fetal. Neonatal Med. 2020. P. 1–8.
  70. Kotsuji F. et al. Transverse uterine fundal incision for placenta praevia with accreta, involving the entire anterior uterine wall: a case series. // BJOG. 2013. Vol. 120, № 9. P. 1144–1149.
  71. Shmakov R.G. et al. Conservative Surgery in Abnormal Placenta Invasion (5-year Experience of V.I. Kulakov National Medical Scientific Centre of Obstetrics, Gynaecology and Perinatal Medicine) // Doctor.Ru. 2019. Vol. 166, № 11. P. 29–34.
  72. Shmakov R.G. et al. Alternative approaches to surgical hemostasis in patients with morbidly adherent placenta undergoing fertility-sparing surgery // J. Matern. Neonatal Med. 2019. Vol. 32, № 12. P. 2042–2048.
  73. Teixidor Viñas M. et al. Prevention of postpartum hemorrhage and hysterectomy in patients with morbidly adherent placenta: a cohort study comparing outcomes before and after introduction of the Triple-P procedure. // Ultrasound Obstet. Gynecol. 2015. Vol. 46, № 3. P. 350–355.
  74. Alanis M. et al. Conservative management of placenta increta with selective arterial embolization preserves future fertility and results in a favorable outcome in subsequent pregnancies. // Fertil. Steril. 2006. Vol. 86, № 5. P. 1514.e3-7.
  75. Clausen C., Lönn L., Langhoff-Roos J. Management of placenta percreta: a review of published cases. // Acta Obstet. Gynecol. Scand. 2014. Vol. 93, № 2. P. 138–143.
  76. Kilicci C. et al. Planned cesarean hysterectomy versus modified form of segmental resection in patients with placenta percreta. // J. Matern. Fetal. Neonatal Med. 2018. Vol. 31, № 22. P. 2935– 2940.
  77. Clark S.L. et al. Hypogastric artery ligation for obstetric hemorrhage. // Obstet. Gynecol. 1985. Vol. 66, № 3. P. 353–356.
  78. Shahin A.Y. et al. Bilateral uterine artery ligation plus B-Lynch procedure for atonic postpartum hemorrhage with placenta accreta. // Int. J. Gynaecol. Obstet. 2010. Vol. 108, № 3. P. 187–190.
  79. Hwu Y.-M. et al. Parallel vertical compression sutures: a technique to control bleeding from placenta praevia or accreta during caesarean section. // BJOG. 2005. Vol. 112, № 10. P. 1420– 1423.
  80. Mei J. et al. Systematic review of uterus-preserving treatment modalities for abnormally invasive placenta. // J. Obstet. Gynaecol. 2015. Vol. 35, № 8. P. 777–782.
  81. Pan Y. et al. Retrospective cohort study of prophylactic intraoperative uterine artery embolization for abnormally invasive placenta. // Int. J. Gynaecol. Obstet. 2017. Vol. 137, № 1. P. 45–50.
  82. Hussein A.M. et al. The role of prophylactic internal iliac artery ligation in abnormally invasive placenta undergoing caesarean hysterectomy: a randomized control trial. // J. Matern. Fetal. Neonatal Med. 2019. Vol. 32, № 20. P. 3386–3392.
  83. Salim R. et al. Precesarean Prophylactic Balloon Catheters for Suspected Placenta Accreta: A Randomized Controlled Trial. // Obstet. Gynecol. 2015. Vol. 126, № 5. P. 1022–1028.
  84. Camuzcuoglu A. et al. Surgical management of 58 patients with placenta praevia percreta. // Wien. Klin. Wochenschr. 2016. Vol. 128, № 9–10. P. 360–366.
  85. Kayem G., Keita H. [Management of placenta previa and accreta]. // J. Gynecol. Obstet. Biol. Reprod. (Paris). 2014. Vol. 43, № 10. P. 1142–1160.
  86. De Mucio B. et al. A systematic review and meta-analysis of cesarean delivery and other uterine surgery as risk factors for placenta accreta. // Int. J. Gynaecol. Obstet. 2019. Vol. 147, № 3. P. 281–291.
  87. Pather S. et al. Maternal outcome after conservative management of placenta percreta at caesarean section: a report of three cases and a review of the literature. // Aust. N. Z. J. Obstet. Gynaecol. 2014. Vol. 54, № 1. P. 84–87.
  88. Timmermans S., van Hof A.C., Duvekot J.J. Conservative management of abnormally invasive placentation. // Obstet. Gynecol. Surv. 2007. Vol. 62, № 8. P. 529–539.
  89. Manzano Nunez R. et al. A meta-analysis of resuscitative endovascular balloon occlusion of the aorta (REBOA) or open aortic cross-clamping by resuscitative thoracotomy in non-compressible torso hemorrhage patients. // World J. Emerg. Surg. 2017. Vol. 12. P. 30.
  90. Chen L. et al. Clinical evaluation of prophylactic abdominal aortic balloon occlusion in patients with placenta accreta: a systematic review and meta-analysis. // BMC Pregnancy Childbirth. 2019. Vol. 19, № 1. P. 30.
  91. Chu Q. et al. Anesthetic management of cesarean section in cases of placenta accreta, with versus without abdominal aortic balloon occlusion: study protocol for a randomized controlled trial. // Trials. 2017. Vol. 18, № 1. P. 240.
  92. Yu S.C.H. et al. Perioperative prophylactic internal iliac artery balloon occlusion in the prevention of postpartum hemorrhage in placenta previa: a randomized controlled trial. // Am. J. Obstet. Gynecol. 2020. Vol. 223, № 1. P. 117.e1-117.e13.
  93. Wei Y. et al. Evaluation of a modified “Triple-P” procedure in women with morbidly adherent placenta after previous caesarean section // Arch. Gynecol. Obstet. 2017. Vol. 296, № 4. P. 737– 743.
  94. Dai Y.M. et al. [Intrauterine balloon tamponade combined with temporary abdominal aortic balloon occlusion in the management of women with placenta accreta spectrum:a randomized controlled trial]. // Zhonghua Fu Chan Ke Za Zhi. 2020. Vol. 55, № 7. P. 450–456.
  95. Suarez S. et al. Uterine balloon tamponade for the treatment of postpartum hemorrhage: a systematic review and meta-analysis. // Am. J. Obstet. Gynecol. 2020. Vol. 222, № 4. P. 293.e1293.e52.
  96. Wei J. et al. Intrauterine double-balloon tamponade vs gauze packing in the management of placenta previa: A multicentre randomized controlled trial. // Medicine (Baltimore). 2020. Vol. 99, № 7. P. e19221.
  97. Робер Д. et al. Клиническое практическое руководство ассоциации акушеров-гинекологов Канады ( SOGC ): диагностика и ведение предлежания плаценты ( placenta previa ). P. 77– 84.

Для продолжения работы требуется Registration
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Table of contents

Данный блок поддерживает скрол*